Dr. Angela Fitch

Dr. Angela Fitch, Founder and CMO of knownwell, shares her expertise on obesity medicine, emphasizing the need for innovative care. She discusses the transformative potential of GLP-1 medications, highlighting their impact beyond obesity treatment to conditions like Alzheimer’s. The conversation also addresses challenges in insurance coverage and the importance of continuous and integrated care. Dr. Fitch advocates for recognizing obesity as a serious medical condition and stresses the necessity of creating a supportive environment for effective treatment.

Spencer Nadolsky, MD, obesity and lipid specialist who builds direct-care models; Angela Fitch, MD, internal/pediatric physician focused on patient-centered metabolic homes; Florencia Halperin, MD, endocrinologist leading telehealth obesity care. They tackle GLP-1 hype, access and cost challenges. They debate medication-only approaches versus wraparound care. They explore payer strategies and what true, sustainable obesity care will require.

Dr. Angela Fitch, Chief Medical Officer of knownwell and former president of the Obesity Medicine Association, joins to unravel the mysteries of menopause-related weight gain. She discusses the hormonal shifts that contribute to this issue and debunks common myths. Dr. Fitch highlights the role of GLP-1 medications in managing weight, stressing the importance of viewing obesity as a health condition rather than a personal failure. Tune in for insights on effective treatment options and a supportive approach to women's health during menopause.